Literature DB >> 28455666

Revisiting 'progressive stroke': incidence, predictors, pathophysiology, and management of unexplained early neurological deterioration following acute ischemic stroke.

Pierre Seners1, Jean-Claude Baron2.   

Abstract

Early neurological deterioration (END) following acute ischemic stroke is a serious clinical event strongly associated with poor outcome. Regarding specifically END occurring within 24 h following stroke onset, apart from straightforward causes such as symptomatic intracranial haemorrhage and malignant edema, the cause of END remains unclear in more than a half of cases. In the latter situation, patients are often referred to as 'progressive stroke', a default clinical category that does not imply underlying mechanisms, precluding informed management. In this review article, we summarize the available evidence on the incidence, predictors, and associated factors of unexplained END, and discuss its underlying pathophysiology. We particularly address the hemodynamic and thrombotic mechanisms that likely play a critical role in unexplained END, and in turn highlight potential new avenues to prevent and manage this ominous event.

Entities:  

Keywords:  Acute stroke; Cerebral ischemia; Deterioration; Penumbra; Thrombolysis

Mesh:

Year:  2017        PMID: 28455666     DOI: 10.1007/s00415-017-8490-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  62 in total

1.  Intracranial pressure elevation reduces flow through collateral vessels and the penetrating arterioles they supply. A possible explanation for 'collateral failure' and infarct expansion after ischemic stroke.

Authors:  Daniel J Beard; Damian D McLeod; Caitlin L Logan; Lucy A Murtha; Mohammad S Imtiaz; Dirk F van Helden; Neil J Spratt
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-11       Impact factor: 6.200

2.  NIH Stroke Scale reliability in ratings from a large sample of clinicians.

Authors:  S Andrew Josephson; Nancy K Hills; S Claiborne Johnston
Journal:  Cerebrovasc Dis       Date:  2006-08-04       Impact factor: 2.762

3.  Floating arterial thrombus related stroke treated by intravenous thrombolysis.

Authors:  P Vanacker; M Cordier; J Janbieh; C Federau; P Michel
Journal:  Cerebrovasc Dis       Date:  2014-10-02       Impact factor: 2.762

Review 4.  Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies.

Authors:  William N Whiteley; Karsten Bruins Slot; Peter Fernandes; Peter Sandercock; Joanna Wardlaw
Journal:  Stroke       Date:  2012-09-20       Impact factor: 7.914

5.  Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.

Authors:  Mayank Goyal; Bijoy K Menon; Wim H van Zwam; Diederik W J Dippel; Peter J Mitchell; Andrew M Demchuk; Antoni Dávalos; Charles B L M Majoie; Aad van der Lugt; Maria A de Miquel; Geoffrey A Donnan; Yvo B W E M Roos; Alain Bonafe; Reza Jahan; Hans-Christoph Diener; Lucie A van den Berg; Elad I Levy; Olvert A Berkhemer; Vitor M Pereira; Jeremy Rempel; Mònica Millán; Stephen M Davis; Daniel Roy; John Thornton; Luis San Román; Marc Ribó; Debbie Beumer; Bruce Stouch; Scott Brown; Bruce C V Campbell; Robert J van Oostenbrugge; Jeffrey L Saver; Michael D Hill; Tudor G Jovin
Journal:  Lancet       Date:  2016-02-18       Impact factor: 79.321

Review 6.  Hyperglycemia: a prothrombotic factor?

Authors:  B A Lemkes; J Hermanides; J H Devries; F Holleman; J C M Meijers; J B L Hoekstra
Journal:  J Thromb Haemost       Date:  2010-05-12       Impact factor: 5.824

7.  Relationship between neurologic deficit severity and final functional outcome shifts and strengthens during first hours after onset.

Authors:  Jeffrey L Saver; Hernan Altman
Journal:  Stroke       Date:  2012-04-05       Impact factor: 7.914

8.  Differential pathophysiological mechanisms of stroke evolution between new lesions and lesion growth: perfusion-weighted imaging study.

Authors:  Oh Young Bang; Gyeong Moon Kim; Chin Sang Chung; Suk Jae Kim; Keon Ha Kim; Pyoung Jeon; Jeffrey L Saver; David S Liebeskind; Kwang Ho Lee
Journal:  Cerebrovasc Dis       Date:  2010-01-30       Impact factor: 2.762

9.  Early neurological deterioration after thrombolysis: Clinical and imaging predictors.

Authors:  Claus Z Simonsen; Marie L Schmitz; Mette H Madsen; Irene K Mikkelsen; Ronil V Chandra; Thabele Leslie-Mazwi; Grethe Andersen
Journal:  Int J Stroke       Date:  2016-05-17       Impact factor: 5.266

Review 10.  Malignant MCA Infarction: Pathophysiology and Imaging for Early Diagnosis and Management Decisions.

Authors:  Wolf-Dieter Heiss
Journal:  Cerebrovasc Dis       Date:  2015-11-19       Impact factor: 2.762

View more
  19 in total

1.  Perfusion Changes of Unexplained Early Neurological Deterioration After Reperfusion Therapy.

Authors:  Jingjing Fu; Ying Zhou; Qingqing Li; Genlong Zhong; Sheng Zhang; Ruiting Zhang; Chang Liu; Minming Zhang; Min Lou
Journal:  Transl Stroke Res       Date:  2019-08-28       Impact factor: 6.829

2.  Change in CSF Dynamics Responsible for ICP Elevation After Ischemic Stroke in Rats: a New Mechanism for Unexplained END?

Authors:  Mohammed S Alshuhri; Lindsay Gallagher; Christopher McCabe; William M Holmes
Journal:  Transl Stroke Res       Date:  2019-08-15       Impact factor: 6.829

3.  Novel Caspase-1 inhibitor CZL80 improves neurological function in mice after progressive ischemic stroke within a long therapeutic time-window.

Authors:  Ling Pan; Wei-Dong Tang; Ke Wang; Qi-Feng Fang; Meng-Ru Liu; Zhan-Xun Wu; Yi Wang; Sun-Liang Cui; Gang Hu; Ting-Jun Hou; Wei-Wei Hu; Zhong Chen; Xiang-Nan Zhang
Journal:  Acta Pharmacol Sin       Date:  2022-05-02       Impact factor: 6.150

4.  The initial glycemic variability is associated with early neurological deterioration in diabetic patients with acute ischemic stroke.

Authors:  Jiaojie Hui; Jianping Zhang; Xuqiang Mao; Zaiwang Li; Xinxin Li; Fengyun Wang; Tao Wang; Qingfang Yuan; Sunwei Wang; Mengjia Pu; Guangjun Xi
Journal:  Neurol Sci       Date:  2018-06-05       Impact factor: 3.307

5.  Early Neurological Deterioration Despite Recanalization in Basilar Artery Occlusion Treated by Endovascular Therapy.

Authors:  Xi Zhong; Xu Tong; Xuan Sun; Feng Gao; Dapeng Mo; Yilong Wang; Zhongrong Miao
Journal:  Front Neurol       Date:  2020-11-19       Impact factor: 4.003

6.  Associations of Interleukin 10, Matrix Metallopeptidase 9, and Legumain with Blood Pressure Variability and Neurologic Outcomes in Patients with Ischemic Stroke.

Authors:  Tianyi Rong; Min He; Yun Hua; Deyan Chen; Miao Chen
Journal:  Int J Gen Med       Date:  2020-12-16

7.  Safety and Efficacy of Endovascular Treatment for Progressive Stroke in Patients With Acute Basilar Artery Occlusion.

Authors:  Yinxu Wang; Yingbing Ke; Lingling Wang; Qing Wu; Jing Zhou; Xiaolin Tan; Jiazuo Liu; Wanjie Geng; Daoyou Cheng; Zongtao Liu; Yinquan Yu; Jiaxing Song; Zhongming Qiu; Fengli Li; Weidong Luo; Jie Yang; Wenjie Zi; Xiaoming Wang; Zhengzhou Yuan
Journal:  Front Neurol       Date:  2021-12-16       Impact factor: 4.003

8.  Extracranial Carotid Plaque Hemorrhage Is Independently Associated With Poor 3-month Functional Outcome After Acute Ischemic Stroke-A Prospective Cohort Study.

Authors:  Fengli Che; Yanfang Liu; Xiping Gong; Anxin Wang; Xiaoyan Bai; Yi Ju; Binbin Sui; Jing Jing; Xiaokun Geng; Xingquan Zhao
Journal:  Front Neurol       Date:  2021-12-14       Impact factor: 4.003

9.  Low-Molecular-Weight Heparin Versus Aspirin in Early Management of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.

Authors:  Hui Xia; Ziyao Wang; Min Tian; Zunjing Liu; Zhenhua Zhou
Journal:  Front Immunol       Date:  2022-02-24       Impact factor: 7.561

10.  Corticospinal Tract Hypoperfusion Associated With Unexplained Early Neurological Deterioration After Intravenous Thrombolysis.

Authors:  Danfeng Zhang; Wansi Zhong; Luowei Chen; Chao Xu; Shenqiang Yan; Ying Zhou; Xiaodong Ma; Min Lou
Journal:  Front Neurol       Date:  2022-03-28       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.